To minimize the number of animals needed for our experiments, we performed key experiments in which we compared using wild type, heterozygous (TTLL3 +/-) and homozygous (ttll3 -/-) mice (suppl. Fig. S6 ). In all parameters tested, wild type and heterozygous (TTLL3 +/-) behaved similar, which is why we decided to pool wild type and TTLL3 +/-mice into a control group for most experiments, in particular for the AOM/DSS model.
Histology and immunohistochemistry
Upon sacrifice, colons were removed from the cecum to the rectum, gently flushed with PBS and fixed in formalin solution (DiaPATH F0046; MicromMicrotech, Francheville, France) for 16 h.
Histological examination was performed on paraffin-embedded colon sections prepared according to "Swiss roll" procedure (Moolenbeek & Ruitenberg, 1981) , and stained with
Hematoxylin and Eosin (H&E), Alcian Blue, Periodic acid-Schiff (PAS) and Masson's
Trichrome for histopathological analysis (Table S2) .
For immunohistochemistry using formalin-fixed and paraffin-embedded tissues were cut into 4-μm sections. Slides were deparaffinized with three 5-min washes using xylene, and pre-treated with 3% hydrogen peroxidase in PBS for 10 min. Antigen retrieval was performed using sodium citrate buffer (pH 6.0) at 95°C for 20 min in a preheated water bath. For BrdU staining, slides were treated with 2 M HCl at 37°C for 1 h, and immediately transferred to 100 mM sodium borate (pH 9.0). Blocking using PBS with 10% goat serum (G9023; Sigma-Aldrich) was performed at room temperature for 1 h. Samples were incubated with primary antibody (Table   S3) for 2 h at room temperature.
For paraffin sections, samples were incubated for 1 h with 4 µg/ml of secondary HRP-coupled anti-mouse or anti-rabbit IgGs (Vector Laboratories, Burlingame, USA) in PBS at room temperature. Signals were visualized by 3,3'-Diaminobenzidine (DAB) kit (SK-4100; Vector Laboratories, Burlingame, USA) and counterstained with Harris hematoxylin (Fisher Scientific, Fremont, USA). Fluorescence staining was also carried out on colon tissue sections fixed in 4%
formaldehyde for 16-h, followed by 24 h incubation in 30% sucrose and cryoprotected with Tissue OCT compound for cryostat sectioning (Q Path 00411243; Labonord, Templemars, France). In these cases, fluorescent-labeled secondary antibodies anti-mouse/rabbit (1:1000;
Molecular Probes, USA) were used. DNA was visualized by staining with 20 µg/ml 4',6'-diamidino-2-phénylindole (DAPI). Coverslips were mounted with Prolong gold anti-fade reagent (P36930; Invitrogen, LifeTechnologies).
AOM/DSS model, tumor histology and histological grading of tumors
For tumor induction and analysis, ttll3 -/-and control littermate mice (7-10 weeks old) were tested for their susceptibility to develop colon tumors in an established mouse model of colitis-induced carcinogenesis. The protocol is based on administration of the mutagenic reagent azoxymethane (AOM), by intraperitoneal injection of AOM (6.25 mg/kg), followed by three cycles (each 6 days) of 2.5% (w/v) dextrane sodium sulphate (DSS) administered in the drinking water (Fig. 5A ). Animals were sacrificed after 65 days, and colons were taken for histological analysis as described above.
Histological grading of AOM/DSS-induced tumors was determined with blinded genotype according to Vienna classification of gastrointestinal epithelial neoplasia (Schlemper et al, 2000) .
Tumors were classified as low-grade dysplasia (LGD, category 3) if they retained apico-basal nuclear orientation, goblet cell differentiation and all-round gland contours. Tumors with highgrade dysplasia (HGD, category 4.1) exhibit both architectural and cytologic changes such as loss of goblet cell differentiation, variation in nuclear size and contour and angular gland contours with focal cribriforming and focal intraglandular necrosis. Intramucosal carcinoma (IMC, category 5.1) was characterized by extensive cribriforming, back-to-back arrangement of glands with loss of lumina and slender, irregular outpouchings consistent with early infiltrative growth (suppl. Fig. S4 ). A certified pathologist confirmed all our analyses.
BrdU incorporation proliferation assay
For proliferation studies, 12-week-old mice were intraperitoneally injected with 100 µg/g Bromodeoxyuridine (BrdU; B9285, Sigma-Aldrich) in PBS. Colons were dissected 2 h or 5 days of injection. Colons were flushed with 10 ml of cold PBS, followed by formalin solution 
β-galactosidase staining
The ttll3 -/-mouse strain contains a central targeting cassette with the reporter gene lacZ (-galctosidase; Skarnes et al, 2011) . In order to visualize the activity of the TTLL3 promoter that drives lacZ expression, we performed 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (Xgal; Sigma-Aldrich) staining in different organs. Animals were perfused with 4% PFA in PBS and organs were cryopreserved as described at the "Histology and Immunohistochemistry" section. Colon tissue was cut to slices of 10 μm thickness. Samples were treated with 0.5% glutaraldehyde for 10 min at room temperature, followed by overnight incubation at 37°C in a staining solution containing 1 mg/ml X-gal, 5 mM potassium ferricyanide (K 3 
Cell culture
Cells were grown at 37°C, 5% CO 2 and 100% humidity. For long-term storage, cell lines were frozen at concentration 1x10 6 to 2x10 6 per ml in medium containing 50% FBS with 10% DMSO.
Cell lines
The cell line HEK293T, the normal human colon cell line CCD 841 CoN (ATCC ® CRL-1790™) and the human carcinoma lines SW480 and DLD1 were cultured in plastic dishes and maintained in DMEM medium (41965-039; Gibco, LifeTechnologies) containing 10 μg/ml penicillinstreptomycin, 2 mM L-Glutamine, 10% fetal bovine serum (FBS; F7524; Sigma-Aldrich).
Human colon cancer cell lines SW480, SW620, DLD1, HT-29, LoVo, COLO 205, HCT116, RKO and T84 contain mutations in APC, KRAS, TP53, PIK3CA, BRAF and CTNNB1 (β-catenin) genes, which are represented in Fig. 6C (Ahmed et al, 2013; Buck et al, 2007; Rowan et al, 2000) .
Mouse embryonic fibroblasts (MEF)
Primary mouse embryonic fibroblasts (MEF) cells were isolated from wild type or ttll3 -/-mouse embryos at embryonic day 13.5 (E13.5) following an established protocol (Michalska, 2007) .
Heads and internal organs were surgically removed, and the remaining tissues were digested with 0.05% trypsin (25300-054; Gibco, LifeTechnologies). To obtain a single-cell suspension, the digestion mixture was pipetted up and down every 5-10 min with a 10-ml pipette for three times.
MEFs were maintained in DMEM medium containing 10 μg/ml penicillin-streptomycin, 2 mM L-glutamine, 10% FBS, 55 μM β-mercapto ethanol and 100 µM of nonessential amino acids (11140; Gibco, LifeTechnologies). MEFs were cryopreserved and stored in liquid nitrogen after isolation (passage 0). At confluence, cells were split 1:3 and could be used for four passages. For TTLL8 silencing experiments, MEFs were cultured on coverslips until reaching confluence. The supplemented medium was replaced by starvation media (medium without serum), and cells were kept in culture for 24 h to induce cell cycle arrest and growth of primary cilia. Cells were fixed with cold methanol for 10 min at -20°C and primary cilia were visualized by immunofluorescence using anti-acetylated tubulin (6-11B-1) antibody (Table S3) shRNA against TTLL8 pHYPER-mTTLL8-siRNA_585 (GUGACCAGAUGCUAAAUCA);
shRNA against TTLL8 pHYPER-mTTLL8-siRNA_729 (GCGAGAAGCAGGAAUUCUU);
Primary colon epithelial cells from neonatal mice
Colon epithelial cells (CECs) were isolated from wild type or ttll3 -/-mice at postnatal day 4 (P4).
Colons were cut into 0.25-cm pieces and digested with 0.05% trypsin for 20 min at 37°C. The suspension was pipetted with a 10-ml pipette every 5 min to obtain single-cell suspension. At the end of the incubation, cells were filtered through a 70-μm strainer and washed with warm DMEM-F12 (1:1) medium (313331-028; Gibco, LifeTechnologies) containing 20% FBS. CECs were plated onto 10 μg/μl fibronectin-coated coverslips and were maintained in DMEM-F12 medium containing 10 μg/ml penicillin-streptomycin and 10% FBS.
For cell cycle analysis, cells were cultured in 6-well dishes. After 48 h incubation cells were fixed with cold 70% ethanol for 2 h at -20°C. Subsequently, the DNA content was visualized by 7-aminoactinomycin D (7-AAD from BD Pharmingen, 1 μg/ml final concentration) staining using a permeabilization solution containing 0.1% Triton X-100 and 100 μg/ml RNAase in water bath at 37°C for 1 h. To assess the amount of cells in division we determined the DNA content of the cells by flow cytometry on a FACSCalibur (BD Biosciences), and determined the mitotic index (percentage of cells in phases S and M).
For induction of ciliogenesis, CECs were cultured on glass coverslips until reaching confluence.
The supplemented medium was removed and cells are kept in culture for 24 h or 48 h with starvation media (medium without serum) to induce cell cycle arrest and allow the growth of primary cilia. Cells were then fixed with cold methanol for 10 min at -20°C and primary cilia were visualized by immunofluorescence using anti-detyrosinated tubulin antibodies (Table S3) .
hTTLL3 Cloning
The sequence of human TTLL3 was only partially predicted in different databases. After prediction of a consensus sequence using the known sequence of murine TTLL3 (van Dijk et al, 2007) , the gene was amplified from testis cDNA (BioChain Institute Inc., USA). The resulting DNA fragments were first cloned into the TOPO ® blunt-end cloning vector (K2875-20;
Invitrogen, LifeTechnologies). After isolation of single clones with inserts of ~2500 bp, these inserts were sequenced. PCR-related mutations were excluded by sequencing and comparing multiple clones. The validated fragments were subcloned into C-terminal YFP-fusion vectors.
Activity tests of the exogenously expressed TTLL3 were performed by transfecting the expression clones into cells and detecting glycylation in immunofluorescence using the monoclonal antibody TAP952.
Microscopy and imaging
Histological analysis were done under light microscopy and slides with tissue sections were scanned with a virtual slide Nanozoomer 2.0 HT scanner using 40x objective, and the ndpi viewer (NanoZoomer Digital Pathology, Hamamatsu, Bridgewater, NJ, USA) was used to acquire images. For fluorescent labeling, images were acquired on 3D microscope (Leica, 
RNA extraction
Mouse organs were dissected and immediately frozen in liquid nitrogen. Tissue crushing and homogenization was done using mortar and pestles under liquid nitrogen. Tissue powders were directly transferred to an appropriate amount of TRIzol reagent (#15596-026, Life Technologies)
for RNA extraction. Chloroform (0.2 ml for each 1 ml of initial TRIzol) was added to homogenized suspension and samples were vigorously shaken for 15 s. After 3 min incubation at room temperature, samples were centrifuged for 15 min at 12,000 g using a microfuge. Aqueous phase was transferred to new tubes containing isopropanol. After 15 min incubation at room temperature, samples were centrifuged for 10 min at 12,000 g and the pellet was washed with 1 ml 70% ethanol. The RNA was dissolved in 30 µl of sterile, RNAase-free water and stored at -80°C.
Concentration of RNA was determined by absorbance at 260 nm using a Nanodrop Spectrophotometer (Thermo Fisher). The quality of the RNA samples was determined by comparing the quality and relative quantities of the 18S and 28S rRNA bands after agarose-gel electrophoresis, staining with ethidium bromide, and visualization with UV light. As cDNA control, Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was amplified with
Reverse transcription PCR

GAPDH-F37 (GCGCCTGGTCACCAGGGCTGC) and GAPDH-R1013
(TCCACCACCCTGTTGCTGTAGCC), 20 cycles.
Quantitative Real-time RT-PCR
Quantitative RT-PCR was performed for the selected genes and to TBP (NM_003194 for human TBP and NM_013684 for mouse Tbp) as endogenous mRNA control. Primers are listed in Table S4 , and PCR conditions are available on request. The RT-PCR protocol using the SYBR Green Master Mix kit on the ABI Prism 7900 Sequence Detection System (Perkin-Elmer Applied Biosystems, Foster City, CA) is described in detail elsewhere (Bieche et al, 1999) . The relative mRNA expression levels of each gene, expressed as the N-fold difference in target gene expression relative to the TBP gene, and termed "Ntarget", was calculated as Ntarget=2 ΔCtsample .
The value of the cycle threshold (ΔCt) of a given sample was determined by subtracting the 13 average Ct value of the target gene from the average Ct value of the TBP gene.
Statistical analysis
Statistical analysis was performed by two-tailed unpaired t-test followed by Mann-Whitney posttest (Fig 1C, F; Fig 3B, D, E; Fig 4B, D, E, G; Fig 5C, D, E) , and ANOVA unpaired test followed by Dunn post-test (Fig 6B) using GraphPad Prism version 5. Figure S1 . Table S2 . Figure S4 . Histological classification of mouse colorectal tumors after AOM/DSS treatment.
Supplementary Figures and Tables
Representative histological images of low-grade dysplasia, high-grade dysplasia and intramucosal carcinoma in colons from AOM/DSS treated mice as used for statistical analysis in (Ahmed et al, 2013; Buck et al, 2007; Gayet et al, 2001; Leibovitz et al, 1976; Rodrigues et al, 1990; Rowan et al, 2000) SW620 CRC stage III x x x (Ahmed et al, 2013; Buck et al, 2007; Leibovitz et al, 1976; Rodrigues et al, 1990) DLD1 CRC stage III x x x x (Ahmed et al, 2013; Buck et al, 2007; Dexter et al, 1979; Rodrigues et al, 1990) HT-29 CRC stage III x x x x x (Buck et al, 2007; Fogh, 1975; Gayet et al, 2001; Rodrigues et al, 1990; Rowan et al, 2000) LoVo CRC stage IV x x (Ahmed et al, 2013; Drewinko et al, 1976; Gayet et al, 2001; Rowan et al, 2000) COLO 205 CRC stage IV x x x x (Buck et al, 2007; Ilyas et al, 1997; Rowan et al, 2000; Semple et al, 1978) HCT 116 CRC stage IV x x x (Ahmed et al, 2013; Brattain et al, 1981; Buck et al, 2007; Gayet et al, 2001; Ilyas et al, 1997; Rowan et al, 2000) RKO CRC stage IV x x (Ahmed et al, 2013; Brattain et al, 1981; Buck et al, 2007) T84 Lung metastasis (Halberg et al, 2000) Ki-67 Proliferating cells (brown) Base of the crypts Scattered throughout the crypt (Johnston et al, 1989) -catenin β-catenin localization (brown) Membrane Cytoplasm and nucleus (Iwamoto et al, 2000; Sheng et al, 1998) 
